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Human Intestine 407 cells respond to hypo-osmotic stress with a
rapid stimulation of compensatory ionic conductances accom-
panied by a transient increase in the activity of the extracellular-
signal-regulated protein kinases Erk-1 and Erk-2. In this study,
we examined the upstream regulators of hypotonicity-induced
Erk-1}Erk-2 activation and their possible role in cell-volume
regulation. The hypotonicity-provoked Erk-1}Erk-2 activation
was greatly reduced in cells pretreated with the specific mitogen-
activated}Erk-activating kinase inhibitor PD098059 and was
preceded by a transient stimulation of Raf-1. Pretreatment of the
cells with PMA, GF 109203X, wortmannin or Clostridium botu-
linum C3 exoenzyme did not appreciably affect the hypotonicity-
provoked Erk-1}Erk-2 stimulation, suggesting the osmosensitive
signalling pathway to be largely independent of protein kinase C
INTRODUCTION
Most mammalian cells respond to changes in cellular volume
with a net movement of water driven by a redistribution of salt
and}or small organic molecules (for reviews see [1,2]). As a
consequence of hyperosmotic stress, cells are triggered to ac-
cumulate osmolytes leading to a subsequent influx of water
(regulatory volume increase). In reverse, hypo-osmotic stress
induces a loss of cellular water due to osmolyte release [regulatory
volume decrease (RVD)]. Despite the extensive research carried
out on cell-volume regulation to date, the molecular mechanisms
of osmosensing and osmosignalling are not completely resolved.
Although differences may exist between cell types, a general
feature of cell signalling in response to hypotonic stress is the
rapid and transient activation of the extracellular-signal-regu-
lated protein kinases Erk-1}Erk-2. Activation of these kinases
has now been reported for a variety of mammalian cell types,
including Intestine 407 cells [3], hepatoma cells [4], hepatocytes
[5], cardiac myocytes [6], astrocytes [7] and C6 glioma cells [8], as
well as for yeast [9].
Erk-1}Erk-2 are members of the superfamily of mitogen-
activated protein kinases (MAP kinases), a group of serine}
threonine kinases that are activated by dual-specificity protein
kinases through phosphorylation on both threonine and tyrosine
Abbreviations used: EGF, epidermal growth factor ; Erk, extracellular-signal-regulated protein kinase ; MAP kinase, mitogen-activated protein kinase ;
MBP, myelin basic protein ; MEK, mitogen-activated/Erk-activating kinase ; PKC, protein kinase C; RVD, regulatory volume decrease; [Ca2+]i,
intracellular Ca2+ concentration ; ECL, enhanced chemiluminescence.
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and p21rho. In contrast, expression of dominant negative RasN17
completely abolished the hypotonicity-induced Erk-1}Erk-2 ac-
tivation. Stimulation of the swelling-induced ion eﬄux was
independent of activation of these mitogen-activated protein
kinases, as revealed by hypotonicity-provoked isotope eﬄux
from "#&I−- and )'Rb+-loaded cells after pretreatment with
PD098059 and after expression of RasN17. In addition, the
epidermal-growth-factor-induced potentiation of the hypo-
tonicity-provoked anionic response did not depend on the
increase in Erk-1}Erk-2 activity but, instead, was found to
depend on Ca#+ influx. Taken together, these results indicate that
hypotonic stress induces Erk-1}Erk-2 activation through the
Ras}Raf-signalling pathway, and argue against a direct role for
this pathway in cell-volume control.
residues. Erk-1}Erk-2 are activated by diverse extracellular
stimuli and affect many important cellular processes via protein
phosphorylation of specific targets (for reviews see [10,11]).
Several different pathways may lead to Erk-1}Erk-2 activation
(reviewed in [12]). The pathway studied in most detail is the
signalling cascade initiated by tyrosine kinase-containing re-
ceptors [e.g. epidermal growth factor (EGF) and platelet-derived
growth factor receptors), which involves activation of the small
G-protein p21ras (Ras). Conversion of Ras–GDP into the active
GTP-bound state, via coupling of the Grb2–Sos complex to the
receptor [13], recruits the Raf-1 kinase to the plasma membrane
[14]. Subsequently, Raf-1 becomes activated and phosphorylates
the mitogen-activated}Erk-activating kinase (MEK) [15], a dual-
specificity protein kinase, which in turn activates Erk-1}Erk-2
[16].
In addition to receptor tyrosine kinases, several G-proteins
coupled to serpentine receptors, as well as cell-surface adhesion
receptors of the integrin family, have been identified as activators
of Erk-1}Erk-2 [17,18]. These receptors have been suggested to
activate the Ras}Erk pathway via activation of PtdIns 3-kinase
(G-protein-coupled receptors) or by binding of the focal adhesion
kinase p125FAK (integrin receptors) to the Grb2–Sos complex
[19,20]. In addition, several Ras-independent pathways have
been reported that lead to Erk-1}Erk-2 activation. For instance,
864 T. van der Wijk and others
Robbins et al. [21] and Chen et al. [22] found that expression of
a dominant negative Ras mutant did not affect Erk-1}Erk-2
activation by G-protein-bound and integrin receptors. Fur-
thermore, EGF has been reported to activate Erk-2 additionally
via Ras-independent pathways, which involve protein kinase C
(PKC) activation or intracellular Ca#+ [Ca#+]
i
increase [23–25].
Using the human fetal jejunum-derived Intestine 407 cell line
as a model, we have recently demonstrated that hypo-osmotic
cell swelling is accompanied by a rapid and transient increase in
tyrosine phosphorylation of several proteins, including p125FAK
and Erk-1}Erk-2, as well as by activation of PtdIns 3-kinase
[3,26]. Furthermore, increased tyrosine phosphorylation was
found to be an essential step in eliciting an RVD response [3].
The finding that EGF not only activates the MAP kinases Erk-
1}Erk-2 but also strongly potentiates the hypotonicity-induced
ion eﬄux [3] suggested a role for Erk-1}Erk-2 in the activation
and}or growth factor potentiation of the osmosensitive anion
eﬄux. This notion was supported by the recent findings that both
the yeast Hog1p and Mpk1p members of the MAP kinase family
are critically involved in cell-volume regulation [9,27].
In this study we have investigated the regulatory pathway
leading to hypotonicity-induced Erk-1}Erk-2 activation and
evaluated the role of theseMAPkinases in cell-volume regulation.
The results presented indicate that the transient osmosensitive
activation of Erk-1}Erk-2 in Intestine 407 cells is downstream of
the Ras}Raf pathway, and independent of PKC, Ca#+ influx and
PtdIns 3-kinase. Treatment of the cells with the specific MEK
inhibitor PD098059 or expression of dominant negative RasN17
prevented the cell-swelling-induced Erk-1}Erk-2 activation, but
neither affected the osmosensitive anion eﬄux or its potentiation
by EGF. Taken together, the results argue against a direct role
for Erk-1}Erk-2 in cell-volume regulation.
MATERIALS AND METHODS
Materials
Radioisotopes ("#&I−, )'Rb+ and [c-$#P]ATP) and enhanced
chemiluminescence (ECL) detection kit were purchased from
Amersham Netherlands B.V. (’s Hertogenbosch, The Nether-
lands). Antibodies and Syntide-2 were obtained from Santa Cruz
Biotechnology Inc. (Santa Cruz, CA, U.S.A.). The MEK in-
hibitor PD098059, myelin basic protein (MBP) and GF 109203X
were purchased from Calbiochem (La Jolla, CA, U.S.A.), Sigma
(St. Louis, MO, U.S.A.) and Biomol (Plymouth Meeting, PA,
U.S.A.) respectively. Protein A–Sepharose was obtained from
Pharmacia Biotech (Uppsala, Sweden). Recombinant Cl. botu-
linum C3 exoenzyme was isolated and prepared as described
previously [28].
Cell culture
Intestine 407 cells were routinely grown as monolayers in
Dulbecco’s modified Eagle’s medium supplemented with 25 mM
Hepes, 10% fetal calf serum, 1% non-essential amino acids,
40 mg}l penicillin and 90 mg}l streptomycin under a humidified
atmosphere of 95% O
#
and 5% CO
#
at 37 °C. Before the
experiments, cells were serum-starved overnight.
Assay of Erk-1/Erk-2 activity
After stimulation, cells were washed once with ice-cold PBS, and
1 ml of lysis buffer was added (1% Triton X-100, 150 mM NaCl,
10 mM Tris}HCl, 1 mM EDTA, 1 mM EGTA, 0±5% Nonidet
P40, 0±2 mM Na
$
VO
%
, 0±2 mM PMSF, 1% aprotinin and
50 lg}ml leupeptin, pH 7±4). After 10 min (0 °C), lysates were
collected, cleared by centrifugation and the supernatants were
incubated with polyclonal anti-Erk-2 antibodies (recognizing
both Erk-2 and, to a lesser extent, Erk-1) for 1 h. Thereafter,
Protein A–Sepharose was added and the mixture was incubated
for another hour. The immunoprecipitates were washed three
times with lysis buffer and three times with kinase buffer (10 mM
Tris}HCl, 150 mM NaCl, 10 mM MgCl
#
, 0±5 mM dithiothreitol,
pH 7±4), and Erk-1}Erk-2 activity was determined by in itro
phosphorylation of MBP. Phosphorylation was carried out in
40 ll of kinase buffer supplemented with 0±5 mg}ml MBP and
25 lM ATP­5 lCi of [c-$#P]ATP (30 min; 37 °C). Reactions
were terminated by the addition of SDS sample buffer. The
samples were boiled for 5 min and subjected to SDS}PAGE.
Radioactivity of MBP was quantified by a phospho-imaging
system (Molecular Imaging System GS-363; Bio-Rad).
Assay of Raf-1 activity
Cells were lysed in 50 mM Hepes, pH 7±5, containing 150 mM
NaCl, 10% glycerol, 1% Triton X-100, 1±5 mM MgCl
#
, 1 mM
EGTA, 10 mM NaF, 1 mM Na
$
VO
%
, 1 mM PMSF and 1%
aprotinin (10 min; 0 °C). Lysates were collected, cleared and
incubated with 1 lg}ml polyclonal rabbit anti-Raf-1. Immune
complexes were bound to Protein A–Sepharose and washed three
times with lysis buffer, twice with 0±5 M LiCl}0±1 M Tris}HCl,
pH 7±5 and once with kinase buffer (25 mM Tris}HCl, 10 mM
MnCl
#
, 1 mM dithiothreitol, 25 mM b-glycerolphosphate,
pH 7±5). Raf-1 activity was determined using Syntide-2 as a
substrate. Phosphorylation was carried out for 20 min at 30 °C in
40 ll of kinase buffer containing 125 lM Syntide-2 and 25 lM
ATP­5 lCi of [c-$#P]ATP. Thereafter, samples were rapidly
centrifuged and 15 ll portions of the supernatants were spotted
on Whatman p81 phosphocellulose paper. After extensive
washing of the paper with 0±85% phosphoric acid, $#P in-
corporation was monitored by phospho-imaging.
Kinase mobility-shift assay
Monolayers of cells were stimulated as indicated in the legends
and incubations were terminated by replacing the medium with
boiling SDS sample buffer. Proteins were separated by SDS}
PAGE and electrophoretically transferred to nitrocellulose.
Proteins were stained with polyclonal anti-Erk-1 antibodies
(recognizing both Erk-1 and Erk-2) or polyclonal anti-Raf-1
antibodies and an ECL Western-blotting detection system ac-
cording to the instructions provided by the manufacturers.
Vaccinia virus infection
Infections with recombinant vaccinia virus encoding the RasN17
mutant and wild-type vaccinia virus were performed as described
previously [23]. After infection, the medium was replaced by
Dulbecco’s modified Eagle’s medium containing 0±25% BSA.
Experiments were performed 16–18 h after infection.
Efflux assays
Confluent monolayers of Intestine 407 cells were loaded with
5 lCi}ml "#&I− or 0±5 lCi )'Rb+ for 2 h in modified Meyler
solution (108 mM NaCl, 4±7 mM KCl, 1±3 mM CaCl
#
, 1 mM
MgCl
#
, 20 mM NaHCO
$
, 0±8 mM Na
#
HPO
%
, 0±4 mM NaH
#
PO
%
,
20 mM Hepes and 10 mM glucose, pH 7±4) under a 95% O
#
}5%
CO
#
humidified atmosphere. Subsequently, the cultures were
washed three times with isotonic buffer (80 mM NaCl, 4±7 mM
KCl, 1±3 mM CaCl
#
, 1 mM MgCl
#
, 10 mM glucose, 95 mM
mannitol and 20 mM Hepes, pH 7±4), and radioisotope eﬄux
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was determined by replacing the medium at 1–2 min intervals.
Hypotonic buffers were prepared by adjusting the concentration
of mannitol. Radioactivity in the medium was determined by c-
radiation counting and expressed as fractional eﬄux per minute
as described previously [29].
RESULTS
Activation and phosphorylation of Erk-1/Erk-2 and Raf-1 in
response to hypo-osmotic cell swelling
Previously, a transient increase in Erk-1 and Erk-2 phos-
phorylation, as demonstrated by a shift in electrophoretic mo-
bility on SDS}PAGE, has been observed after hypotonic stimu-
lation of Intestine 407 cells [3]. Recently, however, it has been
reported that a mobility shift could already be observed after
phosphorylation of either a tyrosine or a threonine residue of
Erk-1}Erk-2, whereas phosphorylation of both residues is re-
quired to induce activation of Erk-1}Erk-2 [10]. Therefore we
quantified hypo-osmotic swelling-induced Erk-1}Erk-2 kinase
activity more directly, using MBP as a substrate. A time course
of Erk-1}Erk-2 activity, as determined in confluent Intestine 407
cultures exposed to a 30% hypotonic shock (70% tonicity), is
shown in Figure 1. Activation started without an apparent lag
phase and peaked after 5 min. Thereafter, the Erk-1}Erk-2
activity slowly declined to prestimulatory levels. No further
activation of Erk-1}Erk-2 was observed within 2–4 h of osmotic
stimulation (results not shown). The osmosensitive stimulation
of Erk-1}Erk-2 is a direct consequence of MEK activity, since
pretreatment of the cells with the specific MEK inhibitor
PD098059 [30], at concentrations that effectively block EGF-
induced increase in MAP kinase activity, greatly reduced Erk-
mediated MBP phosphorylation (Table 1).
In order to establish upstream signalling components of the
hypotonicity-induced MEK}Erk activation, we studied the
effects of osmotic cell swelling on both Raf-1 phosphorylation
and activity. After a lag period of approx. 5 min, a marked
increase in Raf-1 phosphorylation, as evidenced by a decreased
Figure 1 Time course of hypotonic shock-induced phosphorylation and
activation of Erk-1/Erk-2 in Intestine 407 cells
Cells were exposed to 30% hypotonic medium for the times indicated in the presence of
200 lM Na3VO4 (total exposure time was 10 min at all time points). Erk-1/Erk-2 were
immunoprecipitated and enzyme activity was measured using MBP as substrate. Data are
expressed as percentage of activity in cells exposed to isotonic medium (mean³S.E.M., n ¯
3). The inset shows the electrophoretic mobility shift of Erk-1/Erk-2 (p44/p42) induced by a
5 min exposure to 30% hypotonic medium or by EGF (50 ng/ml).
Table 1 Effect of the MEK inhibitor PD098059 on hypotonicity- and EGF-
induced Erk-1/Erk-2 activation
Control or PD098059 (50 lM for 2 h)-pretreated cultures were exposed to isotonic medium,
to 30% hypotonic medium or to 50 ng/ml EGF for 5 min. Thereafter, Erk-1/Erk-2 were
immunoprecipitated and enzyme activity was determined using MBP as substrate. Data are
expressed as percentage of activity in cells exposed to isotonic medium and not pretreated with
PD098059 (mean³S.E.M., n ¯ 3).
Erk-1/Erk-2 activity (% of control)
Pretreatment Isotonic Hypotonic EGF
None 100³11 279³19 303³32
PD098059 46³5 98³26 108³7
Figure 2 Time course of hypotonic shock-induced Raf-1 phosphorylation
and activation
Cells were exposed to 30% hypotonic medium for the times indicated. (A) Electrophoretic
mobility shift of Raf-1. Whole cell lysates were separated by SDS/PAGE followed by Western
blotting. Immunoblots were incubated with anti-Raf-1 antibodies. (B) Raf-1 kinase activity. Raf-
1 was immunoprecipitated and enzyme activity was measured using Syntide-2 as substrate.
Data are expressed as percentage of activity in cells exposed to isotonic medium (mean³S.E.M.,
n ¯ 4).
electrophoretic mobility, was observed, which lasted for more
than 30 min (Figure 2A). The hypotonicity-induced activation of
Raf-1, however, as determined by in itro phosphorylation using
Syntide-2 as a substrate, started immediately and was very
transient, peaking at 2 min after stimulation (Figure 2B). Sub-
sequently, Raf-1 activity rapidly declined to levels even below the
control values. Notably, the decrease in Raf-1 activity coincided
with an increase in Raf-1 phosphorylation.
Osmotic activation of Erk-1/Erk-2 is largely independent of PKC
PKC has previously been identified as an activator of MEK and
Erk-1}Erk-2 through stimulation of Raf-1 kinase [31–33]. To
investigate a possible regulatory role for PKC in the hypotonicity-
induced activation of Erk-1}Erk-2, cells were pretreated with
100 nM PMA to either activate (5 min pretreatment) or down-
regulate (24 h pretreatment) PKC. Whereas activation of PKC
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Table 2 Effect of PMA on the hypotonicity-induced Erk-1/Erk-2 activation
Control and PMA-treated (100 nM for 5 min or 24 h) cells were exposed to 30% hypotonic
medium or isotonic medium for 5 min. Thereafter the cells were lysed and Erk-1/Erk-2 enzyme
activity was determined in immunoprecipitates using MBP as substrate. Data are expressed as
percentage of activity in untreated cells (mean³S.E.M., n ¯ 4).
Erk-1/Erk-2 activity
(% of control)
Pretreatment Isotonic Hypotonic
None 100³15 373³15
PMA (5 min) 325³36 460³16
PMA (24 h) 93³31 267³33
Table 3 Effect of GF 109203X on the hypotonicity-induced Erk-1/Erk-2
activation
Cells were exposed for 5 min to isotonic medium, 30% hypotonic medium or 100 nM PMA in
control and GF 109203X-pretreated (1 lM for 20 min) cultures. Thereafter, Erk-1/Erk-2 were
immunoprecipitated and enzyme activity was determined using MBP as substrate. Data are
expressed as percentage of activity in untreated cells (mean³S.E.M., n ¯ 6).
Erk-1/Erk-2 activity (% of control)
Pretreatment Isotonic Hypotonic PMA (5 min)
None 100³5 331³16 368³27
GF 109203X 120³16 262³37 135³16
by a brief treatment with PMA markedly stimulated Erk-1}Erk-
2 under isotonic conditions, a further increase in activity of the
MAP kinases was still observed after hypo-osmotic cell swelling
(Table 2). Furthermore, down-regulation of PKC by prolonged
PMA treatment only slightly affected hypotonicity-induced Erk-
1}Erk-2 stimulation (Table 2). Pretreatment of cells with the
specific PKC inhibitor GX 109203X (1 lM for 20 min) virtually
abolished the PMA stimulation of Erk-1}Erk-2 activity, but
caused only a minor inhibition of the hypotonicity-provoked
increase in activity (Table 3). Taken together, these results
suggest that hypotonic stress activates Erk-1}Erk-2 principally
via a PKC-independent pathway.
Hypotonic stress-induced Erk-1/Erk-2 activation depends on
active Ras
To investigate the putative involvement of the small GTPase Ras
in the hypotonicity-induced Erk-1}Erk-2 activation, cells were
infected with recombinant vaccinia virus encoding mutant
dominant-negative RasN17 [23]. As compared with control
cultures, infection of the cells with recombinant RasN17 virus
completely abolished the hypotonic-stress-induced Erk-1}Erk-2
activation, whereas mock virus infection affected their stimu-
lation only slightly (Figure 3). Unlike the hypotonicity-provoked
Erk-1}Erk-2 stimulation, activation of these MAP kinases by
EGF was only partially inhibited after expression of RasN17.
This may be due to EGF-triggered activation of alternative Ras-
independent pathways, as has been reported by others [23–25].
In wortmannin-treated (0±1–1 lM; 30 min) cells, neither basal
nor the osmosensitive Erk-1}Erk-2 activities were affected (results
not shown). In addition, pretreatment of the cells with Cl.
botulinum C3 exoenzyme under conditions that inhibited the
hypotonicity-induced anion eﬄux, p125FAK phosphorylation as
Figure 3 Effect of RasN17 expression on hypotonicity- and EGF-induced
Erk-1/Erk-2 activation
Before exposure of the cells to isotonic (*), 30% hypotonic (+) or EGF (50 ng/ml)-containing
(8) medium, cells were transfected with recombinant vaccinia virus expressing RasN17 or with
wild-type virus (Mock). Erk-1/Erk-2 were immunoprecipitated and activity was measured using
MBP as substrate. Data are expressed as percentage of activity in uninfected (Control) cells
exposed to isotonic medium (mean³S.E.M., n ¯ 3). The inset shows a representative
autoradiograph of 32P-labelled MBP separated by SDS/PAGE.
Table 4 Effect of Cl. botulinum C3 exoenzyme on hypotonicity-induced
Erk-1/Erk-2 activation
Cells were exposed for 5 min to isotonic medium or 30% hypotonic medium in the absence
or presence of 50 lg/ml C3 exoenzyme (48 h). After lysis of the cells, Erk-1/Erk-2 were
immunoprecipitated and enzyme activity was measured using MBP as substrate. Data are
expressed as percentage of activity in untreated cultures exposed to isotonic medium
(mean³S.E.M., n ¯ 3).
Erk-1/Erk-2 activity
(% of control)
Pretreatment Isotonic Hypotonic
None 100³3 188³4
C3 exoenzyme 50³8 105³17
well as the PtdIns 3-kinase activation (cf. [26]) markedly reduced
basal Erk-1}Erk-2 activity but did not prevent Erk-1}Erk-2
stimulation by osmotic cell swelling (Table 4), arguing against a
direct involvement of p125FAK and PtdIns 3-kinase in hypo-
tonicity-induced activation of the Ras}Erk cascade.
Erk-1/Erk-2 activation is not involved in triggering the
compensatory ion efflux
Recent studies have demonstrated that in yeast strains defective
in responding to alterations in the tonicity of the medium, the
Hog1p kinase was mutated and inactive, suggesting an important
role for members of the MAP kinase family in cell-volume
regulation [27]. To investigate the role of Erk-1}Erk-2 in the
activation of the osmosensitive anion conductance, hypotonicity-
provoked "#&I− eﬄux was determined in PD098059-pretreated
cultures. As clearly shown in Figure 4(A), PD098059 (50 lM,
2 h) inhibition of MEK did not affect the swelling-induced "#&I−
eﬄux, whereas Erk-1}Erk-2 activation was almost completely
abolished (cf. Table 1). Likewise, the osmosensitive )'Rb+ eﬄux,
indicative of K+-channel activation, remained unaffected in the
presence of PD098059. In addition, no significant decrease in
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Figure 4 Effect of PD098059 and dominant-negative RasN17 on osmosensitive 125I− and 86Rb+ efflux
(A) Radioisotope eﬄux was determined from control (D, ^) and PD098059-treated (50 lM, 2 h ; E, _) cultures. Circles and triangles represent 125I− and 86Rb+ eﬄux respectively. Data are
expressed as fractional isotope eﬄux (mean³S.E.M., n ¯ 3). Arrow indicates a shift from isotonic to 30% hypotonic medium. (B) Control cultures and cells infected with either recombinant vaccinia
virus expressing RasN17 or wild-type vaccinia virus (Mock) were osmotically stimulated (30% hypotonicity) and fractional 125I− eﬄux was determined. Data are expressed as mean³S.E.M.
(n ¯ 6).
Figure 5 Effect of PD098059 and EGTA on EGF-induced potentiation of osmosensitive 125I− efflux
Control (D) and EGF-treated (50 ng/ml for 90 s before osmotic stimulation ; E, x) cells were exposed to a 20% hypotonic medium, and fractional 125I− eﬄux was determined. (A) Effects of
pretreatment with 50 lM PD098059 (PD). (B) Effects of chelating extracellular Ca2+ by the addition of excess EGTA (1±3 mM) during the assay. Data are expressed as mean³S.E.M.
(n ¯ 3). Arrow indicates a shift from isotonic to hypotonic medium.
osmosensitive iodide eﬄux was observed in cells expressing
RasN17 (Figure 4B).
We previously reported an EGF-induced potentiation of the
osmosensitive anion eﬄux in Intestine 407 cells [3]. Since, in
addition to the activation of the Ras}Erk signalling cascade,
EGF is also able to raise [Ca#+]
i
by the release of Ca#+ from
intracellular stores and by activation of plasma-membrane Ca#+
channels [34,35], we studied the effects of EGF in PD098059- and
EGTA-treated cells. As shown in Figure 5, EGF potentiation of
the hypotonicity-induced "#&I− eﬄux was still present in
PD098059-treated cells, but was completely absent from cultures
pretreated with EGTA, indicating that the EGF-mediated in-
crease in anion conductance is not due to activation of Erk-
1}Erk-2 but instead involves a rise in [Ca#+]
i
. Importantly, Erk-
1}Erk-2 activation by EGF or osmotic cell swelling was not
reduced in EGTA-containing medium (results not shown). To
summarize, these results indicate that Erk-1}Erk-2 activity is
involved in neither eliciting nor potentiating the compensatory
osmosensitive anion eﬄux.
DISCUSSION
Osmotic cell swelling rapidly leads to the phosphorylation and}or
activation of a number of signalling enzymes concomitant with
an increase in the conductance of compensatory ion channels.
Among these enzymes, the Erk-1}Erk-2 members of the MAP
kinase family are of particular interest since (1) they are rapidly
and transiently activated, without an apparent lag phase; (2)
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treatment of the cells with the Erk-1}Erk-2 activator EGF
potentiates the hypotonicity-induced anion eﬄux [3] ; (3) in
yeast, the MAP kinases Hog1p and Mpk1p were found to be
crucial for osmoresponse [9,27]. In this paper we analysed the
signalling pathway(s) involved in hypotonicity-induced Erk-
1}Erk-2 activation as well as their role in ion-channel activation.
Hypotonic activation of Erk-1}Erk-2 in Intestine 407 cells was
accompanied by a rapid and transient increase in Raf-1 activity
and was greatly reduced in cells pretreated with the MEK
inhibitor PD098059. In addition, expression of dominant-nega-
tive RasN17 in the cells abolished hypotonicity-induced Erk-
1}Erk-2 activation. These results clearly indicate that the osmotic
cell-swelling-induced activation of Erk-1}Erk-2 is a direct conse-
quence of Ras GDP}GTP exchange, analogous to the activation
of Erk-1}Erk-2 by tyrosine kinase-containing receptors. This
notion is supported by our observations that the osmosensitive
Erk-1}Erk-2 stimulation was largely independent of PKC acting
directly on Raf-1. A hypotonicity-induced phosphorylation of
Raf-1, as reported in this study, was also found in H4IIE
hepatoma and C6 glioma cells [4,8]. However, a clear discrepancy
exists between Raf-1 activation and its phosphorylation. As is
evident from our results, cell-swelling-induced Raf-1 activation
was rapid and very transient, returning to a level even below
prestimulatory activity within 2–5 min, whereas Raf-1 phos-
phorylation was only observed after 5 min of exposure to
hypotonic medium. These observations are in agreement with the
findings of Wartmann et al. [36], who recently reported that
subsequent to its activation by Ras, Raf-1 is immediately
inactivated by hyperphosphorylation.
It still remains to be established how osmotic cell swelling
activates Ras. A possible mechanism involves the Ras-related
GTPase p21rho, which has been identified as an intermediate in
the lysophosphatidic acid- and integrin-receptor-induced Erk-
1}Erk-2 activation [28,37,38].Using Cl. botulinumC3 exoenzyme-
treated cells, we previously demonstrated the involvement of
p21rho in the osmosensitive increase in anion conductance as well
as in p125FAK phosphorylation and PtdIns 3-kinase activation
[26]. Phosphorylated p125FAK as well as PtdIns 3-kinase are able
to activate Ras by respectively direct binding to the Grb2-
SH2}SH3 adaptor protein or by stimulating an Src-like kinase,
which subsequently activates the Shc–Grb2–SOS complex
[19,20]. Our results, however, argue against a role for p21rho,
p125FAK or PtdIns 3-kinase in the signalling cascade leading to
Ras activation, since pretreatment of the cells with C3 exoenzyme
did not prevent hypotonicity-induced Erk-1}Erk-2 activation.
Furthermore, pretreatment of the cells with the PtdIns 3-kinase
inhibitor wortmannin did not affect Erk-1}Erk-2 activation in
Intestine 407 cells. PtdIns 3-kinase independence was also
observed in C6 glioma cells [8] ; however, Erk-1}Erk-2 activation
in astrocytes was found to be completely abolished after PtdIns
3-kinase inhibition [7]. Alternatively, several heterotrimeric G-
proteins have been identified as activators of Ras-type GTPase
(reviewed in [39]). Both pertussis toxin-sensitive G
i
bc subunits as
well as pertussis toxin-insensitive Ga
"#
and Ga
"$
subunits have
been implicated in the activation of MAP kinases. Whereas a G
i
involvement in the hypotonicity-provoked Erk-1}Erk-2 phos-
phorylation was observed in hepatoma cells [4], G
i
is not likely
to be a candidate for Ras activation in Intestine 407 cells since
pretreatment of the cells with pertussis toxin did not affect Erk-
1}Erk-2 activation (T. van der Wijk and B. C. Tilly, unpublished
work). These discrepancies in PtdIns 3-kinase and G
i
involvement
in the hypotonicity-induced Erk-1}Erk-2 activation clearly sug-
gests that upstream regulators may differ between model systems.
In the yeast Saccharomyces cereisiae, both the HOG1 and the
PBS2 genes, which encode respectively a MAP kinase (Hog1p)
and a MAP kinase kinase, are essential for adequately responding
to an increase in extracellular tonicity [27]. Recently, the yeast
osmosensor involved in activating the HOG1 cascade has been
found [40,41]. The osmosensing mechanism belongs to the so-
called ‘ two-component signal-transduction systems’ and consists
of the transmembrane histidine kinase Sln1p (the ‘sensor’) and
the cytosolic Ssk1p response regulator. As, in most mammalian
cell types studied, a rapid activation of Erk-1}Erk-2 is among the
initial signalling events after osmotic cell swelling, it is tempting
to propose a model in which the Ras}Erk cascade plays an
important role in the RVD response. This notion is supported by
several observations that cellular and oncogenic Ras can affect
ion-transport systems [42–44]. Our results, however, using the
specific MEK inhibitor PD098059 as well as the expression of
dominant-negative RasN17, clearly demonstrate that the Ras}
Raf}MEK}Erk cascade is not involved in the activation of
compensatory ionic conductances in hypotonically stimulated
Intestine 407 cells. Moreover, EGF potentiation of the hypo-
tonicity-induced anion eﬄux occurs through elevation of [Ca#+]
i
rather than Erk-1}Erk-2 activation. A potential role for Ca#+
signalling in the potentiation of the hypotonicity-induced ionic
conductances in Intestine 407 cells was previously established by
the observations that Ca#+-mobilizing hormones as well as
thapsigargin and the Ca#+ ionophore A23187 were able to
enhance, but not to trigger, the osmosensitive ionic fluxes [45].
In addition to Erk-1}Erk-2, several other members of the
MAP kinase family have recently been reported. Among these,
the p38 MAP kinase is of particular interest because of its high
homology to Hog1p and, in Intestine 407 cells, its rapid activation
on osmotic cell swelling [46]. It is very unlikely, however, that
p38 is involved in the activation of osmosensitive ionic channels,
because inhibition of p38 MAP kinase, using the specific p38
inhibitor SB-203580, did not block the osmosensitive anion
eﬄux and, unlike Erk-1}Erk-2, activation of p38 MAP kinase
using cytokines or anisomycin did not potentiate the ionic
response [46]. The role of c-Jun N-terminal kinase, a third
member of the MAP kinase family which becomes activated on
cell swelling in cardiac myocytes [6] as well as Intestine 407 cells
(B. C. Tilly, unpublished work), in the regulation of osmo-
sensitive ionic fluxes remains to be established.
To date, little is known about the physiological role of
Erk-1}Erk-2 activation during the RVD response. An increased
expression of the intermediate early genes c-fos and c-jun has
been observed in osmotically stimulated hepatoma cells and
cardiomyocytes [4,6], suggesting a role for Erk-1}Erk-2 in
transcription regulation, maintaining cellular homoeostasis
and}or long-term survival. Activation of the Ras}Erk-signalling
cascade has been widely recognized as the key event leading to
increased cell proliferation. In addition to a rapid and transient
first phase, a second more sustained phase of Erk-1}Erk-2
activation as well as a subsequent translocation to the nucleus
was found to be a prerequisite for G
!
–S transition and cell
division to occur [47,48]. Yet, in Intestine 407 cells, Erk-1}Erk-
2 activation is transient and a second phase is lacking, rendering
a role for cell-swelling-induced Erk-1}Erk-2 activation in cell
proliferation unlikely. A more acute role for hypotonicity-
activated Erk-1}Erk-2 has been proposed for hepatocytes [1,5].
In these cells, a relation has been found between Erk-1}Erk-2
activation and the rapid cell-swelling-induced excretion of
taurocholate into bile. In addition, Erk-2 has been reported to
activate phospholipase A
#
, the enzyme regulating arachidonic
acid release, suggesting a possible involvement of Erk-1}Erk-2 in
intercellular signalling [49]. However, for epithelial cell lines such
as Intestine 407, a functional role for hypotonicity-provoked
Erk-1}Erk-2 activation remains to be established.
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The results of this study also have implications for the
interpretation of our original observation that protein tyrosine
phosphorylation is an essential event in the activation mechanism
of cell-swelling-induced compensatory ionic fluxes [3]. Since the
Ras}Erk cascade is apparently not involved in the regulation of
osmosensitive ionic channels, it follows that the tyrosine kinase(s)
or phosphatase(s) involved in cell volume regulation are distinct
from MEK.
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